Deriving and validating biomarkers associated with autism spectrum disorders from a large-scale resting-state...

Area of Science:

• Neuroscience
• Medical Imaging
• Psychiatry

Background:

• Resting-state functional magnetic resonance imaging (fMRI) is a key tool for investigating brain activity in autism spectrum disorder (ASD).
• Large-scale datasets like the Autism Brain Imaging Data Exchange (ABIDE) provide valuable resources for autism research.
• Translating findings from large datasets to clinical applications is crucial for improving diagnostic and therapeutic strategies.

Purpose of the Study:

• To apply ASD biomarkers derived from the ABIDE dataset to clinical applications.
• To investigate the relationship between MRI-derived biomarkers and clinical indicators in individuals with ASD and neurotypical development (TD).
• To identify specific brain network connectivity patterns associated with ASD.

Main Methods:

• Recruitment of 21 individuals with ASD and 23 TD individuals.
• Application of ASD biomarkers derived from the ABIDE dataset.
• Analysis of resting-state fMRI data focusing on default mode and executive control networks.
• Correlation analysis between MRI biomarkers and scores from the Social Responsiveness Scale (SRS) and Swanson, Nolan, and Pelham Questionnaire IV (SNAP-IV).

Main Results:

• Significant differences in biomarkers from the default mode network (DMN) and executive control network (ECN) were observed between ASD and TD groups.
• Biomarkers derived from the DMN showed a significant negative correlation with SRS raw scores and model factors.
• These findings highlight the potential of connectivity-based biomarkers in ASD.

Conclusions:

• The study successfully translated global autism research efforts into clinical applications.
• Connectivity-based biomarkers, particularly from the DMN, show promise for identifying and understanding ASD.
• This research contributes to the development of objective measures for ASD assessment.